Skip to content

MGB/OAGB Versus RYGB After Failed Sleeve

A Comparison of the Mini/One Anastomosis-Gastric Bypass and Roux-en-Y Gastric Bypass for Conversion of Failed Sleeve Gastrectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03526783
Enrollment
55
Registered
2018-05-16
Start date
2014-10-31
Completion date
2018-09-30
Last updated
2018-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Obesity Surgery, Failed Sleeve Gastrectomy, Roux-en-Y gastric bypass, Mini/One anastomosis gastric bypass

Brief summary

Sleeve Gastrectomy is the most performed bariatric procedure worldwide. But a growing number of data documents that some patients have to be surgical revised due to weight regain or gastro-esophageal reflux disease. This study elaborates weather Roux-en-Y gastric bypass (RYGB) or Mini/One anastomosis gastric bypass (MGB/OAGB) is a better second step procedure after failed sleeve gastrectomy.

Detailed description

All patients who underwent RYGB or MGB/OAGB between October 2014 and December 2016 after failed sleeve gastrectomy will be recorded and analyzed in relation to weight loss, intra- and postoperative complications (Clavien-Dindo) and postoperative morbidity up to one year follow-up.

Interventions

Laparoscopic Roux en Y gastric bypass (150 cm alimentary limb, 50 cm biliopancreaty limb)

PROCEDUREMini/One anastomosis gastric bypass

Laparoscopic Mini/One anastomosis gastric bypass (200 cm biliopancreatic limb)

Sponsors

Sana Klinikum Offenbach
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

Patients with failed sleeve due to * weight regain * weight loss failure * gastro-esophageal reflux disease Grade B

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Weight Loss1 year follow-upTotal Body Weight Loss in %

Secondary

MeasureTime frameDescription
Perioperative Complicationsup to 30 days postsurgeryPerioperative Complications (Clavin-Dindo)
Postoperative Morbidity1 year follow-upPostoperative Morbidity

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026